Cramer's 'Mad Money' Recap: Picking the Right Stocks

Other players like Abbott Labs (ABT), Merck (MRK) and Johnson & Johnson (JNJ) are also in the Hep-C race, but those companies are too huge for a single new drug to move the needle.

Another player is Vertex Pharmaceuticals (VRTX), but that company's drug is too early in development to be a major player at the moment.

That leaves Gilead Sciences (GILD), said Cramer, a company that's trading at just 13.5 times earnings with a 16% growth rate. Gilead's drug, currently known as the catchy GS-7977, is in the same family as Bristol-Myers' drug, only without the side effects. The treatment is a 12-week oral regiment, compared to a 24-week injection routine, and the cure rates are, so far, markedly higher.

Cramer said Gilead is a lot more than just GS-7977. however. The company also leads the way in HIV treatments and has a host of other promising drugs in the pipeline.

Lightning Round

Here's what Cramer had to say about callers' stocks during the "Lightning Round":

Cabot Oil & Gas (COG): "I'd rather wait for a pullback. I say hold off and wait."

Advanced Micro Devices (AMD): "Why? I have nothing to say about those guys. I don't want to touch it."

International Business Machines (IBM): "I say take some profits in IBM and let the rest run."

Frontier Communications (FTR): "The business fell off. They were too confident in their business and I don't like the stock because of that."

Main Street Capital (MAIN): "This one is on fire. I think the stock is a good one."

Ecopetrol SA (EC): "That's a pretty good, well-run company. I think it's better than Total SA (TOT)."

Am I Diversified?

In the "Am I Diversified" segment, Cramer spoke with callers and responded to tweets sent via Twitter to @JimCramer to see if investors' portfolios have what it takes for today's markets.

The first portfolio included: Coca-Cola (KO), McDonald's (MCD), Amazon.com (AMZN), Apple (AAPL) and Kraft Foods (KFT).

Cramer said this portfolio was properly diversified.

The second portfolio's top holdings included: WellPoint (WLP), McDonald's (MCD), MGIC Investment (MTG), Joy Global (JOY) and Excelon (EXC).

Cramer said he was also bullish on this portfolio's diversification.

« First ‹ Previous 1 2 3 4 Next › Last »